While both antigen-presenting cells (APCs, including DCs, macrophages and B cells) and melanoma cells were reported to express CD40 [26, 27], subsequent tSNE analysis by flow cytometry showed that in our experimental setting RGS treatment-induced CD40 expression on CD45− cells but not on APCs (Fig. 5 c). This evidence concerns the gene CD40 and melanoma.